Who Owns Avalyn Pharma Stock?
NASDAQ: AVLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 106.56%
- Institutions (% of float)
- 107.01%
- Held by insiders
- 0.42%
- Institutional holders
- 154
- Institutions 99.6%
- Insiders 0.4%
- Public and other 0.0%
Who owns Avalyn Pharma stock?
Institutional investors own about 106.6% of Avalyn Pharma's shares, spread across 154 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.42% of AVLN.
The largest institutional holders are FMR, LLC (13.89%), Novo Holdings A/S (8.72%) and SR One Capital Management, LP (7.43%). Together, the top 10 institutions control 63.0% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their AVLN positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AVLN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 6.19M | 13.89% | +6.0% |
| Novo Holdings A/S | 3.88M | 8.72% | +100.0% |
| SR One Capital Management, LP | 3.31M | 7.43% | +100.0% |
| Perceptive Advisors Llc | 2.68M | 6.01% | +100.0% |
| Montanova Capital LLC | 2.50M | 5.62% | +100.0% |
| NVP Associates, LLC | 2.27M | 5.10% | 0.0% |
| Wellington Management Group, LLP | 2.20M | 4.95% | +100.0% |
| Price (T.Rowe) Associates Inc | 1.74M | 3.90% | +100.0% |
| Catalio Capital Management, LP | 1.68M | 3.76% | +100.0% |
| T. Rowe Price Investment Management, Inc. | 1.60M | 3.60% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AVLN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.23M | 2.77% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 627.19K | 1.41% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 534.44K | 1.20% |
| iShares Trust-iShares Russell 2000 ETF | 466.56K | 1.05% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 415.61K | 0.93% |
| T. Rowe Price Health Sciences Fund, Inc. | 396.07K | 0.89% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 385.81K | 0.87% |
| T. Rowe Price Small-Cap Value Fund, Inc. | 342.11K | 0.77% |
| T. Rowe Price New Horizons Fund, Inc. | 332.41K | 0.75% |
| Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund | 318.46K | 0.72% |
Frequently asked questions
Who is the largest shareholder of Avalyn Pharma?
FMR, LLC is the largest institutional shareholder of AVLN, owning 13.89% of shares outstanding (6.19M shares) as of its latest 13F filing.
What percentage of Avalyn Pharma is owned by institutions?
Institutions own about 106.6% of AVLN shares and 107.0% of the public float.
How much of Avalyn Pharma do insiders own?
Insiders, such as officers and directors, own about 0.42% of AVLN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.